Data for ST002949
Metabolite structure | All data | F1 | F2 |
---|---|---|---|
1,1^-(Tetrahydro-6a-hydroxy-2,3a,5-trimethylfuro[2,3-d]-1,3-... | 81.53 | 3.84 | |
1-Methylnicotinamide | 44.23 | 8.39 | |
2-Benzofurancarboxaldehyde | 58.50 | 54.79 | |
3-Amino-2-piperidone | 10.06 | 13.50 | |
4-Hydroxybenzaldehyde | 9.91 | 16.58 | |
(±)-Tryptophan | 8.03 | 9.97 | |
Betaine aldehyde | 59.98 | 51.12 | |
Hypoxanthine | 44.23 | 8.39 | |
Indoleacetaldehyde | 2362.39 | 2035.97 | |
L-Carnitine | 547.31 | 396.35 | |
L-Gulose | 34.14 | 41.61 | |
L-Tyrosine | 10.81 | 18.38 | |
LysoPE(16:0/0:0) | 36.80 | 49.02 | |
Octadecylamine | 834.21 | 324.75 | |
PC(16:0/16:0) | 43.82 | 3175.73 | |
PC(20:3(8Z,11Z,14Z)/20:1(11Z)) | 215.17 | 186.89 | |
Phytosphingosine | 36.01 | 28.42 | |
Pipecolic acid | 23.68 | 28.40 | |
Pyro-L-glutaminyl-L-glutamine | 226.03 | 337.32 | |
threo-Syringoylglycerol | 46.54 | 8.80 |
Factors:
F1 | Treatment:Ankylosing Spondylitis |
F2 | Treatment:healthy control |